By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novartis Pharma S.A. 

26 rue de la Chapelle
BP 349
Huningue    F - 68330  France
Phone: 33-3-89-69-55-55 Fax: +33-3-89-69-55-03




Company News
Human Genome Sciences, Inc. (HGSI) Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule 8/28/2007 7:31:18 AM
Human Genome Sciences, Inc. (HGSI) Announces $40 Million Milestone Payment Related to Albuferon(R) Development 8/28/2007 7:23:27 AM
European Experts Recommended Against Approving Novartis AG's Antifungal Drug Mycograb 11/17/2006 11:36:28 AM
ADHD Drugs To Have Stronger Warning; Include Novartis International AG (NVS)'s Dexedrine And GlaxoSmithKline Biologicals (GSK)'s Ritalin 8/22/2006 8:23:53 AM
Novartis Pharma Obtains Additional Approval For Its Proprietary Immunosuppressant Neoral 6/16/2006 2:59:32 PM
Formulatrix Announces Licensing Agreement 11/1/2005 3:18:44 PM
Novartis AG (NVS) Paying US$5.1 Billion For Rest Of Shares In Chiron Corporation (CHIR) 10/31/2005 10:26:01 AM
Novartis Pharma AG (NVS) In UK Biotech Deal Worth Up To $375 Milllon10/19/2005 5:13:16 PM
Novartis Pharma AG (NVS) Warns Of Skin Problems With Epilepsy Drug10/19/2005 5:13:13 PM
Novartis Pharma AG (NVS) Obtains Rights From Otsuka Pharmaceutical Co., Ltd. To Develop New Treatment For Dry Eye10/19/2005 5:12:38 PM